Key result
CardShock and SOFA scores outperform APACHE-II and IABP-Shock II in predicting in-hospital cardiogenic shock mortality.
Why the study?
Cardiogenic shock remains associated with high morbidity and mortality despite advances, and accurate risk stratification may improve management.
Do established risk prediction models (APACHE-II, CardShock, IABP-Shock II, SOFA) accurately predict in-hospital mortality in patients with cardiogenic shock?
Observational (n=3,021)
Do established risk prediction models (APACHE-II, CardShock, IABP-Shock II, SOFA) accurately predict in-hospital mortality in patients with cardiogenic shock?
Effect estimate: AUC 0.76 (95% CI 0.72-0.81)
Established risk scores for cardiogenic shock demonstrate only modest prognostic accuracy for in-hospital mortality, highlighting the need for improved risk stratification models.
Modest discrimination by existing scores warrants caution in cardiogenic shock prognostication; leaves open need for refined prediction models.
Objectives: Despite advances in medical therapy, reperfusion, and mechanical support, cardiogenic shock remains associated with excess morbidity and mortality. Accurate risk stratification may improve patient management. We compared the accuracy of established risk scores for cardiogenic shock. Methods: Patients admitted to tertiary care center cardiac care units in the province of Alberta in 2015 were assessed for cardiogenic shock. The Acute Physiology and Chronic Health Evaluation-II (APACHE-II), CardShock, intra-aortic balloon pump (IABP) Shock II, and sepsis-related organ failure assessment (SOFA) risk scores were compared. Receiver operating characteristic curves were used to assess discrimination of in-hospital mortality and compared using DeLong’s method. Calibration was assessed using the Hosmer-Lemeshow goodness-of-fit test. Results: The study included 3021 patients, among whom 510 (16.9%) had cardiogenic shock. Patients with cardiogenic shock had longer median hospital stays (median 11.0 vs 4.1 days, P < .001) and were more likely to die (29.0% vs 2.5%, P < .001). All risk scores were adequately calibrated for predicting hospital morality except for the APACHE-II score (Hosmer-Lemeshow P < .001). Discrimination of in-hospital mortality with the APACHE-II (area under the curve [AUC]: 0.72, 95% confidence interval [CI]: 0.66-0.76) and IABP-Shock II (AUC: 0.73, 95% CI: 0.68-0.77) scores were similar, while the CardShock (AUC: 0.76, 95% CI: 0.72-0.81) and SOFA (AUC: 0.76, 95%CI: 0.72-0.81) scores had better discrimination for predicting in-hospital mortality. Conclusions: In a real-world population of patients with cardiogenic shock, existing risk scores had modest prognostic accuracy, with no clear superior score. Further investigation is required to improve the discriminative abilities of existing models or establish novel methods.
No takes yet. Share an insight, caveat, or question.
Miller et al. (2019) conducted an observational in Cardiogenic shock (n=3,021). CardShock and SOFA risk scores vs. APACHE-II and IABP-Shock II risk scores was evaluated on Discrimination of in-hospital mortality (AUC 0.76, 95% CI 0.72-0.81). The CardShock and SOFA risk scores demonstrated better discrimination for in-hospital mortality (AUC 0.76; 95% CI 0.72-0.81 for both) compared to APACHE-II and IABP-Shock II in cardiogenic shock.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: